{
    "clinical_study": {
        "@rank": "122958", 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the safety and effectiveness of ribavirin, administered\n      as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV\n      pneumonia in bone marrow and peripheral blood transplant recipients."
        }, 
        "brief_title": "Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients", 
        "completion_date": "March 2003", 
        "condition": "Respiratory Syncytial Virus Infections", 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia", 
                "Respiratory Syncytial Virus Infections", 
                "Virus Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study enrolls 90 transplant recipients with positive nasal/throat culture specimens for\n      Respiratory Syncytial Virus (RSV) infection. Patients are randomized into one of two groups:\n      investigational treatment or standard treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA:\n\n          -  2 years of age or older.\n\n          -  Are not pregnant or breast-feeding and agree to use a reliable birth control method\n             for the duration of the study.\n\n          -  Are a blood or bone marrow transplant recipient.\n\n          -  Have evidence of upper respiratory tract infection.\n\n          -  Have nasopharyngeal-throat samples positive for RSV.\n\n        EXCLUSION CRITERIA:\n\n          -  Are known to be HIV positive.\n\n          -  Have pneumonia.\n\n          -  Require a ventilator to breathe.\n\n          -  Are pregnant.\n\n          -  Are breast-feeding and are unwilling to stop breast-feeding.\n\n          -  Are receiving treatment with certain other drugs for RSV."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": "90", 
        "firstreceived_date": "March 6, 2002", 
        "id_info": {
            "nct_alias": "NCT00001098", 
            "nct_id": "NCT00031473", 
            "org_study_id": "97-038"
        }, 
        "intervention": {
            "intervention_name": "Virazole (Ribavirin) Inhalation Solution", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ribavirin"
        }, 
        "keyword": [
            "Ribavirin", 
            "RSV"
        ], 
        "lastchanged_date": "August 26, 2010", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "University of Alabama at Birmingham (CASG)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duarte", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91010"
                    }, 
                    "name": "City of Hope National Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California, San Francisco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32610"
                    }, 
                    "name": "University of Florida"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "J. Whitcomb Riley Hosp for Chldrn - Indianapolis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "University of Maryland"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64134"
                    }, 
                    "name": "St. Luke's Hospital (Kansas City, MO)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68198"
                    }, 
                    "name": "University of Nebraska Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "SUNY Upstate Medical University"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized Phase III Study to Evaluate the Safety and Efficacy of Ribavirin Inhaled Solution in Preventing Progression of Upper Respiratory Tract Respiratory Syncytial Virus Infection to RSV Pneumonia in Blood and Bone Marrow Transplant (BMT) Recipient", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00031473"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "November 1997", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2003"
    }, 
    "geocoordinates": {
        "City of Hope National Medical Center": "34.139 -117.977", 
        "J. Whitcomb Riley Hosp for Chldrn - Indianapolis": "39.769 -86.158", 
        "SUNY Upstate Medical University": "43.048 -76.147", 
        "St. Luke's Hospital (Kansas City, MO)": "39.1 -94.579", 
        "University of Alabama at Birmingham (CASG)": "33.521 -86.802", 
        "University of California, San Francisco": "37.775 -122.419", 
        "University of Chicago": "41.878 -87.63", 
        "University of Florida": "29.652 -82.325", 
        "University of Maryland": "39.29 -76.612", 
        "University of Minnesota": "44.98 -93.264", 
        "University of Nebraska Medical Center": "41.252 -95.998"
    }
}